Rapid results: implementing new guidelines for promising outcomes in the prevention of mother-to-child transmission of HIV
Abstract:
In November 2010, Rwanda adopted a new protocol corresponding to 2010 World Health Organization (WHO) guidelines for the prevention of MTCT (PMTCT) that aim to reduce transmission to <5% and <2% in breastfeeding (BF) and non-BF populations respectively. Azidothymidine-based monotherapy was replaced with tenofovir-based triple antiretroviral therapy (HAART) prophylaxis/treatment. HIV-exposed infants now receive once-daily nevirapine (NVP) from birth to six weeks.
Publication date:
Saturday, January 1, 2011
Language:
English